- Home
- SKIN vs ACV Comparison
SKIN vs ACV Comparison
Compare SKIN & ACV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKIN
- ACV
- Stock Information
- Founded
- SKIN 1997
- ACV 2015
- Country
- SKIN United States
- ACV United States
- Employees
- SKIN N/A
- ACV N/A
- Industry
- SKIN Package Goods/Cosmetics
- ACV Finance/Investors Services
- Sector
- SKIN Consumer Discretionary
- ACV Finance
- Exchange
- SKIN Nasdaq
- ACV Nasdaq
- Market Cap
- SKIN 280.3M
- ACV 234.1M
- IPO Year
- SKIN N/A
- ACV N/A
- Fundamental
- Price
- SKIN $2.17
- ACV $22.69
- Analyst Decision
- SKIN Sell
- ACV
- Analyst Count
- SKIN 2
- ACV 0
- Target Price
- SKIN $1.13
- ACV N/A
- AVG Volume (30 Days)
- SKIN 1.4M
- ACV 38.8K
- Earning Date
- SKIN 08-07-2025
- ACV 01-01-0001
- Dividend Yield
- SKIN N/A
- ACV 9.20%
- EPS Growth
- SKIN N/A
- ACV N/A
- EPS
- SKIN N/A
- ACV N/A
- Revenue
- SKIN $310,064,000.00
- ACV N/A
- Revenue This Year
- SKIN N/A
- ACV N/A
- Revenue Next Year
- SKIN $5.73
- ACV N/A
- P/E Ratio
- SKIN N/A
- ACV N/A
- Revenue Growth
- SKIN N/A
- ACV N/A
- 52 Week Low
- SKIN $0.78
- ACV $16.82
- 52 Week High
- SKIN $2.56
- ACV $23.74
- Technical
- Relative Strength Index (RSI)
- SKIN 60.54
- ACV 52.39
- Support Level
- SKIN $1.53
- ACV $22.40
- Resistance Level
- SKIN $2.56
- ACV $22.90
- Average True Range (ATR)
- SKIN 0.18
- ACV 0.26
- MACD
- SKIN 0.07
- ACV -0.01
- Stochastic Oscillator
- SKIN 64.55
- ACV 55.73
About SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.
About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest
Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.